Left ventricular (LV) hypertrophy and dysfunction due to hypertension have been established as risk markers for stroke in hypertensive patients. The purpose of this study was to examine the differences in LV hypertrophy and dysfunction between patients with cerebral hemorrhage and those with cerebral infarction. The study enrolled 23 hypertensive patients with cerebral infarction, 25 hypertensive patients with cerebral hemorrhage, and 24 normotensive controls (controls). Standard echocardiography was performed; LV mass index was measured to evaluate LV hypertrophy, and conventional diastolic transmitral flow velocities were measured to assess LV diastolic function, which was also evaluated by measuring mitral annular velocities using tissue Doppler echocardiography. The Tei index, which reflects both the diastolic and systolic function of LV, was also calculated. The LV mass index and Tei index were significantly higher in cerebral hemorrhage (116 ± 38 g/m 2 and 0.57 ± 0.13) than those in controls (92 ± 20 g/m 2 and 0.46 ± 0.10) ( p < 0.05). In contrast, the LV mass index and Tei index in cerebral infarction (100 ± 27 g/m 2 and 0.46 ± 0.12) were not different from those in controls. Thus, the Tei index was significantly worse in the patients with cerebral hemorrhage than in those with cerebral infarction ( p < 0.05). On the other hand, the parameters, which reflect diastolic function, showed no significant differences between cerebral hemorrhage and cerebral infarction. These results indicate that LV hypertrophy and dysfunction due to hypertension are more apparent in patients with cerebral hemorrhage than in those with cerebral infarction.
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hypertension; cerebral hemorrhage; cerebral infarction; echocardiography; left ventricular hypertrophy. Hypertension is a powerful risk factor for both cerebral hemorrhage and infarction (Fukasawa 1975; Arai et al. 1976; Kawamura et al. 1998; Eguchi et al. 2004; Eto et al. 2005; Kario et al. 2006) . It is well known that left ventricular (LV) hypertrophy as assessed by echocardiography in hypertensive patients is a predictive parameter of cardiovascular events, including cerebral hemorrhage and infarction (Verdecchia et al. 1998 ). In addition, left ventricular diastolic of hypertension. All of the normotensive control subjects and hypertensive patients were diagnosed as having no cardiac diseases and normal cardiac function. The blood pressure of all hypertensive patients was less than 160/100 mmHg. None of the subjects had a history of any atherosclerotic cardiovascular diseases, except stroke. This study excluded patients with cerebral embolism, which was diagnosed by brain magnetic resonance imaging or clinical findings. Blood pressure was determined in the outpatient clinic using the conventional cuff method. Echocardiography and blood sampling were performed in the morning after a 12-hr overnight fast. Plasma total cholesterol, triglyceride, and HbA1c were measured by standard laboratory techniques. The plasma B-type natriuretic peptide (BNP) level was measured using the Determiner BNP Test TM by enzyme immunoassay (Kyowa Medex Co., Ltd., Tokyo). This protocol was approved by the Ethics Committee of Kagawa General Rehabilitation Center. Informed consent was obtained from all participants.
Echocardiographic examination
Two-dimensional and M-mode echocardiography was performed using an echocardiographic instrument (Vivid Seven System; GE, Horten, Norway). We first measured the following LV structural parameters by M-mode echocardiography: the ventricular septal thickness at the chordae tendineae level (VS), the left ventricular end-diastolic dimension at the chordae tendineae level (LVDd), the left ventricular posterior wall thickness at the chordae tendineae level (PW), the dimensions of the ascending aorta, and the end-systolic dimension of the left atrium. The LV mass was calculated according to the American Society of Echocardiography conventions (Devereux and Wallerson 1987) [LVDd] 3 ) + 0.6. The LV mass index was calculated as the LV mass divided by the body surface area. We next measured the parameters of LV diastolic function by recording the conventional transmitral flow velocity using pulsed Doppler echocardiography (Appleton et al. 2000) . The conventional transmitral flow velocity was recorded from the apical transducer position with the sample volume situated between the mitral leaflet tips. The peak early transmitral flow velocity (E velocity) and the peak late transmitral flow velocity (A velocity) were recorded, and the ratio of E to A (E/A ratio) was calculated. The deceleration time of E velocity (DcT) was measured as the time interval from the dysfunction, detected by echocardiography, indicates a risk of cardiovascular events in hypertensive patients (Schillaci et al. 2002) . However, there are few comparative analyses (Janssens et al. 1995) of left ventricular hypertrophy and diastolic dysfunction between hypertensive patients with cerebral hemorrhage and those with infarction.
Because hypertension is a powerful risk factor for both cerebral hemorrhage and infarction (Kario et al. 2006) , left ventricular hypertrophy and diastolic dysfunction are expected to be detected by echocardiography in patients with either of these types of stroke. However, if the role of hypertension in stroke onset differs between these stroke types, the findings of left ventricular hypertrophy and diastolic dysfunction may likewise differ between patients with one type and those with the other. The purpose of this study was to examine whether ventricular hypertrophy and diastolic dysfunction differ between patients with cerebral hemorrhage and those with infarction.
METHODS

Subjects and protocol
The present study enrolled 48 consecutive patients diagnosed as having essential hypertension at Kagawa General Rehabilitation Center between April 2006 and the end of August 2007. Although all patients had a history of stroke at least one year prior to the study, their condition with regard to stroke was stable during their participation in the study. The hypertensive patients were divided into 2 groups: those with cerebral infarction (Cerebral infarction group: 60 ± 8 years) and those with cerebral hemorrhage (Cerebral hemorrhage group: 59 ± 7 years). The study also included age-matched normotensive control subjects (Normotensive controls group: 61 ± 6 years) and Hypertensive patients who had never had a stroke (Hypertensives without stroke group: 62 ± 6 years) for the comparison of echocardiographic findings. The normotensive control group consisted of healthy subjects with blood pressure less than 140/90 mmHg. They visited Kagawa General Rehabilitation Center for rehabilitative treatment for orthopedic diseases and underwent routine echocardiography for cardiac assessment. The hypertensive patients without stroke visited Kagawa General Rehabilitation Center for the treatment E-wave peak to the decline of the velocities to baseline values. We measured the Tei index, which reflects both the systolic and diastolic function of the LV (Tei et al. 1995) ; details of the measurement method have been published previously (Tei et al. 1996) . Defined as the sum of the isovolumic contraction time and isovolumic relaxation time divided by the ejection time, the Tei index is based on Doppler recordings of LV inflow and outflow. It is derived as (a -b)/b, where "a" is the interval between cessation and the onset of mitral inflow and "b" is the ejection time of LV outflow. In measuring "a" and "b", we confirmed that the preceding RR intervals were the same in each patient.
Furthermore, pulsed wave tissue Doppler imaging (TDI) was performed by activating the TDI function in the same machine. The sample volume was located at the septal side of the mitral annulus. Peak early (E′) and late (A′) diastolic mitral annulus velocities and the ratio of early to late peak velocities (E′/A′) were obtained. In addition, the ratio of E velocity to E′ velocity (E/E′) was calculated. It is well known that mitral annulus velocity determined by TDI is a relatively preload-independent variable and is superior to conventional transmitral flow velocity for the early diagnosis of many heart diseases (Nikitin and Witte 2004) .
Statistical analysis
Data are expressed as means ± S.D. Statistical analysis was performed with SPSS/Windows, version 11.5J (SPSS, Chicago, IL, USA). Dichotomous data are presented as frequencies for background variables. Categorical variables were compared by the chi-square test. For the comparison of mean values among the groups, one-way analysis of variance (ANOVA) followed by Scheffe's test was used. P values of less than 0.05 were considered statistically significant. Table 1 summarizes the clinical characteristics of the hypertensive patients with stroke, hypertensive patients without stroke, and normotensive controls. There were no significant differences in age, gender, or body mass index among the 4 groups. There were no significant differences in the proportion of patients with diabetes mellitus or dyslipidemia, or in the results of blood examination except for BNP. Although the BNP levels in the hypertensive patients with stroke were significantly higher than those in normotensive controls ( p < 0.05), there was no difference between the 2 groups of hypertensive patients with stroke. There were no significant differences in heart rate among the 4 groups. Although the hypertensive patients had significantly higher blood pressure than the normotensive controls, no difference was observed among the 3 groups of hypertensive patients. Similarly, the percentage of patients using anti-hypertensive medication was roughly the same among the 3 groups of hypertensive patients.
RESULTS
Clinical characteristics of hypertensive patients with stroke, hypertensive patients without stroke, and normotensive controls
Echocardiographic parameters in hypertensive patients with stroke, hypertensive patients without stroke, and normotensive controls
Echocardiographic parameters of the hypertensive patients with stroke, hypertensive patients without stroke, and normotensive controls are summarized in Table 2 . The LV wall thickness of the ventricular septum and posterior wall were greater in hypertensive patients with cerebral hemorrhage than in the normotensive controls. No significant difference in the left ventricular mass index (LVMI) was observed between the hypertensive patients with cerebral infarction and the normotensive controls. However, the LVMI was significantly greater in the hypertensive patients with cerebral hemorrhage than in the normotensive controls ( p < 0.05) (Fig. 1) .
Regarding the parameters of LV diastolic function obtained from transmitral LV inflow velocities and mitral annulus velocities, only the deceleration time of the E velocity (the time interval from the E-wave peak to the decline of the velocities to baseline values) in the hypertensive patients with cerebral infarction (219 ± 63 msec) and hemorrhage (212 ± 50 msec) differed from that in the normotensive controls (173 ± 46 msec) ( p < 0.05). The increase in the deceleration time of the E velocity indicated the LV diastolic dysfunction in the stroke patients. However, the parameters of LV diastolic function showed no differences between the hypertensive patients with cerebral hemorrhage and those with cerebral infarction. No significant difference in the Tei index, which reflects both the diastolic and systolic function of LV, was observed between the hypertensive patients with cerebral infarction and normotensive controls. However, the Tei index was significantly greater (worse) in the hypertensive patients with cerebral hemorrhage than in those with cerebral infarction and normotensive controls ( p < 0.05) (Fig. 1) .
DISCUSSION
This study compared data regarding echocardiographic abnormalities between patients with cerebral hemorrhage and those with infarction. The comparison led us to the following conclusions: (1) LV hypertrophy was more apparent in hypertensive patients with cerebral hemorrhage than in those with cerebral infarction, and (2) although the parameters of LV diastolic function showed no differences between hypertensive patients with cerebral hemorrhage and those with cerebral infarction, the Tei index, which reflects both diastolic and systolic function in the LV, revealed a greater decrease in LV function in hypertensive patients with cerebral hemorrhage than in those with cerebral infarction.
Although hypertension is a powerful risk factor for both cerebral hemorrhage and infarction (Kario et al. 2006) , several studies (al-Roomi et al. 1992; Janssens et al. 1995) have reported that hypertension was more prevalent in patients with cerebral hemorrhage than in those with cerebral infarction. Our results revealed that LV hypertrophy assessed by LV mass index and LV dysfunc- 2.2 ± 2.6 22.5 ± 3.4 23.1 ± 3.1 23.1 ± 2.4 Dyslipidemia (%) 7 (29%) 8 (33%) 8 (35%) 7 (28%) Diabetes (%) 3 (13%) 4 (17%) 4 (17%) 4 (16%) HR 69 ± 7 65 ± 11 70 ± 10 67 ± 8 Systolic BP (mmHg) 105 ± 11 133 ± 22** 129 ± 13** 124 ± 14** Diastolic BP (mmHg) 64 ± 9 76 ± 13** 76 ± 9** 75 ± 10** FBS (mg/dl) 90 ± 9 92 ± 10 93 ± 9 93 ± 7 TC (mg/dl) 187 ± 30 193 ± 22 189 ± 22 182 ± 29 HDLC (mg/dl) 44 ± 13 58 ± 17 50 ± 9 50 ± 11 Triglyceride (mg/dl) 98 ± 44 115 ± 40 111 ± 31 107 ± 25 BNP (pg/ml) 7.4 ± 3.7 7.3 ± 3.5 15.5 ± 13.1* 15.9 ± 13.6* Drug administration (%) 0 (0%)
BMI, body mass index; BP, blood pressure; FBS, fasting blood glucose; TC, total cholesterol; HDLC, high-density lipoprotein cholesterol; BNP, plasma B-type natriuretic peptide; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin-II receptor blockers; CCB, calcium channel blockers. *p < 0.05, **p < 0.001 vs normotensive controls.
tion assessed by Tei index were more apparent in patients with cerebral hemorrhage than in those with cerebral infarction. In addition, hypertensive patients without stroke also showed LV hypertrophy and dysfunction. The degree of echocardiographic abnormalities in hypertensive patients without stroke was more severe than that in infarctive patients and milder than that in hemorrhagic patients (Fig. 1) . Because these echocardiographic abnormalities are likely to be hypertensive alterations, our results support the concept that hypertension is more important in hemorrhagic than infarctive stroke even if it is important in the etiologies of both. Because we treated only 4 normotensive patients with cerebral infarction during the study period, we did not have enough patients to allow a statistical analysis of the echocardiographic data. However, the mean LV mass index (84 ± 24 g/m 2 ) and the mean Tei index (0.39 ± 0.10) of these 4 normotensive patients with cerebral infarction were normal. These data also suggest that hypertension is more important in hemorrhagic than in infarctive stroke. In the present study, the LV diastolic functional parameters derived from conventional transmitral Doppler showed no significant differences among the cerebral hemorrhage group, cerebral infarction group, and normotensive control group. This may be attributed to the limitation in assessing LV diastolic dysfunction by conventional transmitral Doppler indexes such as E/A ratio. As such indexes are influenced by LV preload, patients with severe heart failure show a pseudonormalization of LV transmitral Doppler flow patterns even if their LV diastolic function is impaired (Poerner et al. 2003) . Furthermore, the LV diastolic functional parameters derived from tissue Doppler imaging also showed no significant differences between the cerebral hemorrhage and infarction groups. It is well known that mitral annulus velocity determined by tissue Doppler imaging is a relatively preload-independent variable and is superior to conventional transmitral Doppler indexes for the early diagnosis of many heart diseases (Farias et al. 1999) . The difference in LV diastolic dysfunction between the 2 subtypes of stroke might be very small in the present study. Because the study participants had been treated with antihypertensive drugs after their strokes, the LV diastolic function might have improved by the time the echocardiographic examinations were performed. However, the slightly higher plasma BNP levels in both cerebral hemorrhage and infarction groups (Table 1) indicated that LV dysfunction remained to some degree in both groups. Although the plasma BNP level did not differ between the 2 groups, the Tei index was significantly higher in the cerebral hemorrhage group than in the cerebral infarction group. Therefore, we consider that not only LV hypertrophy but also dysfunction may be more severe in patients with cerebral hemorrhage than in those with cerebral infarction due to hypertension.
The present study has several limitations. First, we have no data regarding antihypertensive therapy before the participants had their strokes.
However, a previous study (Jørgensen et al. 1995) reported that hypertension and blood pressure recorded on admission for stroke attack were not predictors of stroke type. In the present study, the blood pressure of hypertensive patients with stroke upon their first visit to our hospital was the same between infarctive (146 ± 24/82 ± 16 mmHg) and hemorrhagic (150 ± 21/84 ± 14 mmHg) patients. Thus, blood pressure did not differ between these groups at the start of rehabilitation for stroke. A second limitation is that we have no echocardiographic data from the time of their stroke attack. Because the control of blood pressure was good in all patients when this study was performed, antihypertensive therapy after their stroke attack might have improved LV hypertrophy and dysfunction. Finally, this crosssectional study cannot provide data regarding how antihypertensive therapy after stroke would change cardiac abnormalities. A previous study (Jørgensen et al. 1995) reported that stroke type per se had no influence on stroke prognosis. We cannot determine whether the cardiac abnormalities observed in the hypertensive patients in this study influenced their prognoses or not. A further follow-up study may be needed to elucidate stroke prognosis by assessing cardiac abnormalities in hypertensive patients with stroke.
In conclusion, hypertensive patients with cerebral hemorrhage or infarction exhibit LV hypertrophy and dysfunction. Such cardiac alterations are more apparent in patients with cerebral hemorrhage than in those with cerebral infarction.
